BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7250859)

  • 1. [Comparison of bioavailability of pilocarpine].
    Eyal E; Nemet P; Korczyn AD; Carel R
    Harefuah; 1980 Dec; 99(12):445-7. PubMed ID: 7250859
    [No Abstract]   [Full Text] [Related]  

  • 2. Pilocarpine hydrolysis: clinical significance.
    Ellis PP; Littlejohn K
    Invest Ophthalmol; 1973 Dec; 12(12):931-3. PubMed ID: 4768597
    [No Abstract]   [Full Text] [Related]  

  • 3. The pilocarpine Ocusert Delivery System.
    Flach A
    Trans Pac Coast Otoophthalmol Soc Annu Meet; 1974; 55():179-208. PubMed ID: 4480721
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigations of the efficacy and bio-availability of different pilocarpine eye drops].
    Tapasztó I; Boross F
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(6):315-8. PubMed ID: 7129108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the bioavallability of pilocarpine from its ophthalmic solutions.
    Soliman MM; El-Agizy HK; Elhofy OA; Salama HA; El Nimr AE; Khalil RM; Kassem MA
    Bull Ophthalmol Soc Egypt; 1978; 71(75):219-26. PubMed ID: 549717
    [No Abstract]   [Full Text] [Related]  

  • 6. Noninvasive pharmacodynamic and bioelectrometric methods for elucidating the bioavailability mechanisms of ophthalmic drug preparations.
    Smolen VF
    Prog Drug Res; 1981; 25():421-60. PubMed ID: 7031766
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmaceutical and clinical evaluation of soluble pilocarpine eye films].
    Maĭchuk IuF; Erichev VP
    Vestn Oftalmol; 1981; (2):48-50. PubMed ID: 7015673
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hypotensive and miotic action of stabilized solutions of physostigmine and physostigmine-pilocarpine (experimental data)].
    Fauziia Saied AKh; Sporova NA; Kondrat'eva TS
    Vestn Oftalmol; 1978; (5):17-8. PubMed ID: 706040
    [No Abstract]   [Full Text] [Related]  

  • 9. Vehicle effects on ophthalmic bioavailability: the influence of different polymers on the activity of pilocarpine in rabbit and man.
    Saettone MF; Giannaccini B; Teneggi A; Savigni P; Tellini N
    J Pharm Pharmacol; 1982 Jul; 34(7):464-6. PubMed ID: 6126549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of methylcellulose and carboxymethylcellulose on the biological availability of eye drops containing pilocarpine hydrochloride].
    Nerlo H; Wieluńska Z
    Ann Univ Mariae Curie Sklodowska Med; 1981; 36():67-71. PubMed ID: 7052782
    [No Abstract]   [Full Text] [Related]  

  • 11. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proxodolol, a new domestic preparation for lowering intraocular pressure in glaucoma].
    Ermakova VN; Iuzhakov SD; Mashkovskiĭ MD; Kolomoĭtseva EM
    Vestn Oftalmol; 1995; 111(2):4-7. PubMed ID: 7645180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine.
    Saettone MF; Giannaccini B; Chetoni P; Galli G; Chiellini E
    J Pharm Pharmacol; 1984 Apr; 36(4):229-34. PubMed ID: 6144768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of pilocarpine and carbacholine following administration of the drug].
    Wolter-Czerwińska H; Nowak A
    Klin Oczna; 1973 Jul; 43(7):785-8. PubMed ID: 4727953
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bioactivity and effect of a mixture of pilocarpine and lysine on the pupil and intraocular pressure in rabbits].
    Veselovský J; Oláh Z; Veselovská Z; Veselá A
    Cesk Slov Oftalmol; 1998 Nov; 54(6):353-61. PubMed ID: 9919787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraocular pressure in rabbits by telemetry II: effects of animal handling and drugs.
    Dinslage S; McLaren J; Brubaker R
    Invest Ophthalmol Vis Sci; 1998 Nov; 39(12):2485-9. PubMed ID: 9804159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension].
    Xu Y; Chen Z; Song J
    Zhonghua Yan Ke Za Zhi; 2002 Dec; 38(12):721-4. PubMed ID: 12654220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of apraclonidine 1% versus pilocarpine 4% for prophylaxis of intraocular pressure spike after argon laser trabeculoplasty.
    Ren J; Shin DH; Chung HS; Birt CM; Glover BK; Juzych MS; Hughes BA; Kim C
    Ophthalmology; 1999 Jun; 106(6):1135-9. PubMed ID: 10366082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.